Is this you? Create Your Porfile
Avatar

Nicole Kaneider

Novartis

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Nicole Kaneider is active.

Explore More

Publication

Featured researches published by Nicole Kaneider.

Archive | 2004

Use of Sphingosine-1-Phosphate (S1P) Receptor Agonists For the Treatment of Brain Degenerative Diseases

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Use of sphingosine-1-phosphate (S1P) receptor agonists in combination with a second agent for the treatment of brain degenerative diseases

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Utilisation d'agonistes du recepteur de sphingosine-1-phosphate pour le traitement de maladies degeneratives des fonctions cerebrales

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Verwendung von sphingosin-1-phosphat (s1p) rezeptor-agonisten zur behandlung von degenerativen gehirnerkrankungen Use of sphingosine 1-phosphate (S1P) receptor agonist for the treatment of degenerative brain disorders

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Uso de agonistas de receptores de 1-fosfato de esfingosina (s1p) para el tratamiento de enfermedades cerebrales degenerativas.

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Utilisation relative aux maladies cerebrales degeneratives

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Use of agonists of sphingosine 1-phosphate (S1P) for the treatment of degenerative brain diseases.

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Use of agonists of sphingosine 1-phosphate (S1P) in combination with a second agent for the treatment of degenerative brain diseases

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Uso de agonistas de receptores de 1-fosfato de esfingosina (s1p) en combinación con un segundo agente para el tratamiento de enfermedades cerebrales degenerativas

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Archive | 2004

Utilisation d'agonistes du récepteur de sphingosine-1-phosphate (S1P) en combinaison avec un deuxième principe actif pour le traitement de maladies dégénératives des fonctions cérébrales.

Volker Brinkmann; Nicole Kaneider; Christian J. Wiedermann

Explore More

Collaboration

Dive into the Nicole Kaneider's collaboration.

Top Co-Authors
Avatar

Christian J. Wiedermann

Novartis

View shared research outputs
Top Co-Authors
Avatar

Volker Brinkmann

Novartis

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge